The Evolution of Neuromodulation: Greater Accessibility, Portability, and Integration into Routine Care
When many healthcare providers hear the term transcranial magnetic stimulation (TMS), they picture a patient sitting in a specialized treatment chair in a clinic, receiving a scheduled series of treatments over several weeks.
That’s understandable.
For years, repetitive transcranial magnetic stimulation (rTMS) has been associated primarily with office-based treatment programs, particularly in mental health settings.
But neuromodulation has evolved.
Today, migraine providers are increasingly encountering a different form of magnetic stimulation: single-pulse transcranial magnetic stimulation (sTMS), a portable technology designed for patient-directed use outside of the clinic.
Understanding the difference can help clinicians navigate a rapidly growing area of headache/ migraine care.
How sTMS Differs from rTMS
Although both therapies use magnetic stimulation, they serve different purposes and are delivered differently.
Repetitive transcranial magnetic stimulation (rTMS) typically involves repeated magnetic pulses administered during scheduled sessions in a clinical setting. Treatment often requires specialized equipment, trained personnel, and multiple visits over a defined period.
Single-pulse transcranial magnetic stimulation (sTMS), by contrast, delivers brief magnetic pulses that patients can administer themselves according to prescribed treatment protocols.
The distinction is important.
Rather than requiring a clinic appointment, sTMS is designed to be used where migraines actually occur—at home, at work, while traveling, or wherever symptoms begin.
For migraine patients, that flexibility can make a meaningful difference.
Why Patients Prefer Portable Interventions
Anyone who treats migraine regularly knows that attacks rarely happen at convenient times. During meetings.
On vacation.
During a child’s soccer game.
While driving home from work.
Patients often tell us they want treatments that fit into their lives rather than treatments that require their lives to revolve around treatment.
Portable neuromodulation addresses that reality.
For some patients, the appeal isn’t simply avoiding medication. It’s having access to a treatment option that can be used quickly, independently, and without coordinating another appointment or pharmacy visit.
That convenience doesn’t replace clinical effectiveness—but it does influence adherence and patient satisfaction.
And in chronic disease management, convenience often matters more than we realize.
A Nurse’s Take on Real-World Use
From a nursing perspective, one of the most interesting aspects of portable neuromodulation is how it changes patient conversations.
Instead of focusing exclusively on prescriptions, side effects, and refills, discussions can expand to include self-management strategies and non-pharmacologic options.
Patients often appreciate having another tool available—particularly those who have experienced medication fatigue, treatment limitations, or concerns about medication overuse.
Of course, portable neuromodulation is not appropriate for every patient. It is not a cure.
And it should not be presented as a replacement for comprehensive migraine care. But as neuromodulation continues to evolve, one thing is becoming increasingly clear: The future of migraine treatment is not simply about developing more therapies.
It’s about giving patients more ways to access the right therapy at the right time. And sometimes, this involves shifting treatment from the clinical setting to the patient’s everyday environment.
References
- George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. American Journal of Psychiatry. 2011.
- Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, sham-controlled trial. The Lancet Neurology. 2010;9(4):373-380.
- Puledda F, Goadsby PJ. An update on non-invasive neuromodulation for migraine and cluster headache. Cephalalgia. 2017;37(7):685-691.
- Moisset X, Pereira B, Ciampi de Andrade D, et al. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. The Journal of Headache and Pain. 2020;21(1):142.
- American Headache Society. Consensus Statement: Update on Integrating New Migraine Treatments Into Clinical Practice. Headache. 2021.
